Not available
Quote | Hikma Pharmaceuticals Plc ADR (OTCMKTS:HKMPY)
Last: | $46.50 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $46.50 |
High: | $0 |
Low: | $0 |
Volume: | 319 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Hikma Pharmaceuticals Plc ADR (OTCMKTS:HKMPY)
2024-03-20 04:02:20 ET More on Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC (HKMPF) Q4 2023 Earnings Call Transcript Historical earnings data for Hikma Pharmaceuticals PLC Dividend scorecard for Hikma Pharmaceuticals PLC Financial information for Hikma...
2024-02-22 12:33:03 ET Hikma Pharmaceuticals PLC (HKMPF) Q4 2023 Earnings Conference Call February 22, 2024, 07:00 AM ET Company Participants Susan Ringdal - EVP, Strategic Planning and Global Affairs Riad Mishlawi - CEO Khalid Nabilsi - CFO Bill Larkins - He...
Message Board Posts | Hikma Pharmaceuticals Plc ADR (OTCMKTS:HKMPY)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $HKMPY News Article - Hikma expands impact in Canada with launches of new sterile injec | whytestocks | investorshangout | 03/09/2023 1:10:46 PM |
whytestocks: $HKMPY News Article - Civica Rx and Hikma Announce Shipments of Heparin and Seven Other | whytestocks | investorshangout | 12/10/2019 4:45:42 PM |
Hikma Pharmaceuticals plc. due diligence | stocktrademan | investorshub | 07/06/2014 11:36:13 AM |
chartguy89: HKMPY 49.26 Stock Charts $HKMPY 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 10:42:03 PM |
chartguy89: HKMPY Stock Charts Last: +6.98 Wednesday, February 26, 2014 at 8:06:32 PM $HKMPY | chartguy89 | investorshangout | 02/27/2014 1:06:44 AM |
News, Short Squeeze, Breakout and More Instantly...
Hikma Pharmaceuticals Plc ADR Company Name:
HKMPY Stock Symbol:
OTCMKTS Market:
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Hikma Pharmaceuticals PLC (“Hikma”), a multinational pharmaceutical company, today announced an agreement to promote Guardant Health’s portfolio of liquid and tissue biopsy tests for cancer screenin...
Rakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North Africa PR Newswire SAN DIEGO , Aug. 10, 2023 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company devel...
Hikma expands impact in Canada with launches of new sterile injectable medicines Canada NewsWire Builds on company's growing position in Canadian sterile injectables market LONDON , March 9, 2023 /CNW/ -- Hikma Pharmaceuticals PLC (Hikma), the multination...